BRIDGEWATER, N.J., Nov. 27 /PRNewswire-FirstCall/ -- National Starch and Chemical Company, a member of the ICI Group (NYSE: ICI) , announced that it has acquired the resistant starch business and the worldwide rights to the broad technology and intellectual property portfolio in high amylose resistant starch from Penford Australia Ltd., a wholly owned subsidiary of Penford Corporation. The agreement covers the use of products for general applications as well as the exclusive rights for products used in human nutrition.
The technology platform, made available through a royalty bearing licensing structure, encompasses resistant starch products for human nutrition including prebiotic and probiotic effects, colonic health, fat metabolism, glycemic response, weight regulation, body composition and treatment and prevention of disease. The commercial business acquired includes the supply of hi-maize resistant starch to customers in Australasia and elsewhere.
"This technology, combined with National Starch's existing proprietary technology portfolio, enables the company to more rapidly grow its already successful human nutrition platform," said Gary Zwiercan, group vice president, Advanced Ingredients Group.
The value of the transaction represents less than one percent of ICI Group net assets.
National Starch and Chemical Company, headquartered in Bridgewater, N.J., is a member of the ICI Group. National Starch is a worldwide manufacturer of adhesives, specialty polymers, electronic and engineering materials, natural polymers and advanced ingredients, with sales of $2.6 billion.